My CME -- WEDNESDAY, Oct. 6 (HealthDay News) -- The adenosine A1-receptor antagonist rolofylline does not appear beneficial in treating acute heart failure patients with renal dysfunction, according to research published in the Oct. 7 issue of the New England Journal of Medicine.
